JP2008546825A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008546825A5 JP2008546825A5 JP2008518812A JP2008518812A JP2008546825A5 JP 2008546825 A5 JP2008546825 A5 JP 2008546825A5 JP 2008518812 A JP2008518812 A JP 2008518812A JP 2008518812 A JP2008518812 A JP 2008518812A JP 2008546825 A5 JP2008546825 A5 JP 2008546825A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- use according
- alkyloxy
- hydrogen
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 22
- 125000003545 alkoxy group Chemical group 0.000 claims 18
- 229910052739 hydrogen Inorganic materials 0.000 claims 17
- 239000001257 hydrogen Substances 0.000 claims 17
- 125000005843 halogen group Chemical group 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 13
- 125000004432 carbon atom Chemical group C* 0.000 claims 11
- 208000035143 Bacterial infection Diseases 0.000 claims 10
- 208000022362 bacterial infectious disease Diseases 0.000 claims 10
- 150000002431 hydrogen Chemical class 0.000 claims 9
- 229930195734 saturated hydrocarbon Natural products 0.000 claims 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- -1 cyano, hydroxy Chemical group 0.000 claims 8
- 150000002430 hydrocarbons Chemical group 0.000 claims 8
- 125000004414 alkyl thio group Chemical group 0.000 claims 7
- 208000015181 infectious disease Diseases 0.000 claims 6
- 239000002253 acid Substances 0.000 claims 5
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000004122 cyclic group Chemical group 0.000 claims 4
- 125000001188 haloalkyl group Chemical group 0.000 claims 4
- 125000003386 piperidinyl group Chemical group 0.000 claims 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 3
- 239000005977 Ethylene Substances 0.000 claims 3
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 claims 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 3
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims 3
- 239000003242 anti bacterial agent Substances 0.000 claims 3
- 229960003085 meticillin Drugs 0.000 claims 3
- 125000001624 naphthyl group Chemical group 0.000 claims 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 3
- 241000295644 Staphylococcaceae Species 0.000 claims 2
- 241000191967 Staphylococcus aureus Species 0.000 claims 2
- 239000003926 antimycobacterial agent Substances 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 2
- 125000002757 morpholinyl group Chemical group 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 2
- 125000004364 3-pyrrolinyl group Chemical group [H]C1=C([H])C([H])([H])N(*)C1([H])[H] 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 241000194031 Enterococcus faecium Species 0.000 claims 1
- 241000192125 Firmicutes Species 0.000 claims 1
- 206010062207 Mycobacterial infection Diseases 0.000 claims 1
- 125000000815 N-oxide group Chemical group 0.000 claims 1
- 229930182555 Penicillin Natural products 0.000 claims 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims 1
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 229940034014 antimycobacterial agent Drugs 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004604 benzisothiazolyl group Chemical group S1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000004438 haloalkoxy group Chemical group 0.000 claims 1
- 125000002632 imidazolidinyl group Chemical group 0.000 claims 1
- 125000002636 imidazolinyl group Chemical group 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 125000002346 iodo group Chemical group I* 0.000 claims 1
- 125000001786 isothiazolyl group Chemical group 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 229940049954 penicillin Drugs 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 claims 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 1
- 125000004306 triazinyl group Chemical group 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05105769.3 | 2005-06-28 | ||
| EP05105769 | 2005-06-28 | ||
| PCT/EP2006/063556 WO2007000436A1 (en) | 2005-06-28 | 2006-06-26 | Quinoline derivatives as antibacterial agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008546825A JP2008546825A (ja) | 2008-12-25 |
| JP2008546825A5 true JP2008546825A5 (enExample) | 2009-08-20 |
| JP5193859B2 JP5193859B2 (ja) | 2013-05-08 |
Family
ID=35445742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008518812A Expired - Fee Related JP5193859B2 (ja) | 2005-06-28 | 2006-06-26 | 抗菌剤としてのキノリン誘導体 |
Country Status (33)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9790186B2 (en) | 2009-07-21 | 2017-10-17 | Trustees Of Dartmouth College | Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection |
| AU2013254670B2 (en) | 2012-04-27 | 2017-03-30 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| ES2576491T3 (es) | 2012-04-27 | 2016-07-07 | Janssen Pharmaceutica, N.V. | Derivados de quinolina antibacterianos |
| CN105037497B (zh) * | 2015-03-27 | 2018-06-26 | 中牧实业股份有限公司 | 一种恩拉霉素的提纯方法 |
| WO2017035288A1 (en) * | 2015-08-27 | 2017-03-02 | Trustees Of Dartmouth College | Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| DE19937116A1 (de) * | 1999-08-06 | 2001-02-08 | Bayer Ag | Moxifloxacin Kochsalzformulierung |
| SI1527050T1 (sl) * | 2002-07-25 | 2010-08-31 | Janssen Pharmaceutica Nv | Kinolinski derivati in njihova uporaba kot mikobakterijski inhibitorji |
| MXPA06013888A (es) * | 2004-05-28 | 2007-01-26 | Janssen Pharmaceutica Nv | Uso de derivados de quinolina sustituidos para el tratamiento de enfermedades micobacterianas resistentes a los farmacos. |
| EE05394B1 (et) * | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
-
2006
- 2006-06-25 JO JOP/2006/0189A patent/JO3270B1/ar active
- 2006-06-26 MX MX2008000082A patent/MX2008000082A/es active IP Right Grant
- 2006-06-26 AP AP2008004300A patent/AP2733A/xx active
- 2006-06-26 HR HRP20161704TT patent/HRP20161704T1/hr unknown
- 2006-06-26 DK DK06763891.6T patent/DK1898910T3/en active
- 2006-06-26 ME MEP-2016-291A patent/ME02690B/me unknown
- 2006-06-26 JP JP2008518812A patent/JP5193859B2/ja not_active Expired - Fee Related
- 2006-06-26 NZ NZ564339A patent/NZ564339A/en not_active IP Right Cessation
- 2006-06-26 EP EP06763891.6A patent/EP1898910B1/en not_active Expired - Lifetime
- 2006-06-26 WO PCT/EP2006/063556 patent/WO2007000436A1/en not_active Ceased
- 2006-06-26 PL PL06763891T patent/PL1898910T3/pl unknown
- 2006-06-26 LT LTEP06763891.6T patent/LT1898910T/lt unknown
- 2006-06-26 US US11/917,923 patent/US20100204270A1/en not_active Abandoned
- 2006-06-26 HU HUE06763891A patent/HUE031268T2/en unknown
- 2006-06-26 AU AU2006263884A patent/AU2006263884B2/en not_active Ceased
- 2006-06-26 EA EA200800152A patent/EA014163B1/ru unknown
- 2006-06-26 CN CN2006800313527A patent/CN101252928B/zh not_active Expired - Fee Related
- 2006-06-26 CA CA2612623A patent/CA2612623C/en not_active Expired - Lifetime
- 2006-06-26 RS RS20161121A patent/RS55408B1/sr unknown
- 2006-06-26 SG SG201007977-0A patent/SG166799A1/en unknown
- 2006-06-26 KR KR1020087002248A patent/KR101423229B1/ko not_active Expired - Fee Related
- 2006-06-26 BR BRPI0612534A patent/BRPI0612534B8/pt not_active IP Right Cessation
- 2006-06-26 UA UAA200714716A patent/UA91549C2/ru unknown
- 2006-06-26 PT PT67638916T patent/PT1898910T/pt unknown
- 2006-06-26 SI SI200632126A patent/SI1898910T1/sl unknown
- 2006-06-26 ES ES06763891.6T patent/ES2606772T3/es not_active Expired - Lifetime
- 2006-06-27 AR ARP060102760A patent/AR057654A1/es unknown
- 2006-06-27 TW TW095123051A patent/TWI392494B/zh not_active IP Right Cessation
- 2006-06-27 MY MYPI20063045 patent/MY151030A/en unknown
-
2007
- 2007-12-20 ZA ZA200711149A patent/ZA200711149B/xx unknown
- 2007-12-25 IL IL188394A patent/IL188394A/en active IP Right Grant
-
2008
- 2008-01-25 NO NO20080481A patent/NO341283B1/no not_active IP Right Cessation
-
2012
- 2012-08-07 US US13/568,597 patent/US20130030017A1/en not_active Abandoned
-
2016
- 2016-12-20 CY CY20161101322T patent/CY1118515T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009503024A5 (enExample) | ||
| HRP20131116T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| CA2566544A1 (en) | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases | |
| Nigo et al. | What’s new in the treatment of enterococcal endocarditis? | |
| JP2009503025A5 (enExample) | ||
| CA2493225A1 (en) | Quinoline derivatives and their use as mycobacterial inhibitors | |
| HRP20160585T1 (hr) | Antibakterijski derivati kinolina | |
| CA3081423A1 (en) | Antibacterial compounds | |
| JP2006504658A5 (enExample) | ||
| JP2014525420A5 (enExample) | ||
| JP2010511668A5 (enExample) | ||
| JP2016507533A5 (enExample) | ||
| NZ595448A (en) | Hydroxythienoquinolones and related compounds as anti-infective agents | |
| WO2010047737A3 (en) | Antimicrobial indoline compounds for treatment of bacterial infections | |
| JP2012501349A5 (enExample) | ||
| JP2010511667A5 (enExample) | ||
| FI3006038T3 (fi) | Oritavansiinin yksittäisannokset bakteeri-infektion hoitoon tai ehkäisyyn | |
| JP2012513467A5 (enExample) | ||
| HRP20210484T1 (hr) | Antimikrobna sredstva koja se temelje na imidazolu | |
| HRP20140206T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| CN108368079A (zh) | 治疗细菌感染的化合物及方法 | |
| JP2008546824A5 (enExample) | ||
| JP2010507576A5 (enExample) | ||
| ME01245B (me) | Antibakterijski hinolinski derivati | |
| JP2024009968A5 (enExample) |